BioNTech ADRs Fall 10% On Lower 2Q Revenue
09 August 2022 - 2:08AM
Dow Jones News
By Kathryn Hardison
American depositary receipts of BioNTech SE fell 10% Monday to
$165.21 after the company said its second-quarter earnings and
revenue fell.
The German biotechnology company, which has developed one of the
most widely sold Covid-19 vaccines with Pfizer Inc., reported a
profit of 1.67 billion euros ($1.70 billion), down from EUR2.79
billion during the same period a year earlier.
Revenue fell to EUR3.20 billion from EUR5.31 billion a year
earlier.
The company said its variant-adapted Covid-19 vaccine should
help increase demand later this year.
Write to Kathryn Hardison at kathryn.hardison@wsj.com
(END) Dow Jones Newswires
August 08, 2022 11:53 ET (15:53 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Apr 2023 to Apr 2024